A retrospective analysis of the burden and treatment patterns of esophageal cancer over one year in a tertiary healthcare institution in the Western Himalayan region
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20251835Keywords:
Dysphagia, Esophageal cancer, Palliative care, Radiation oncologyAbstract
Background: Esophageal cancer (EC) is a highly aggressive malignancy with a poor prognosis, particularly in advanced stages. By 2024, EC incidence is expected to increase by 63.5% over 2020. The objective of the study was to analyse the EC burden and treatment patterns in Dr. RPGMC, Kangra, Himachal Pradesh, Radiotherapy and Oncology Department, with a focus on palliative radiotherapy.
Methods: A retrospective analysis of 83 patients treated at our institute between 2023 and 2024 for esophageal cancer (7.9% of all new cases). Patients received treatment in two groups: palliative (n=34) and radical (n=49). Analysis was done on demographic, histopathological, cancer staging, and treatment modalities data. Self-expandable metallic stent (SEMS) implantation, palliative chemotherapy, or radiotherapy were all considered forms of palliative care. It was evaluated if palliative radiotherapy improved dysphagia.
Results: Almost 8% of all cancers were esophageal cancers. There were 30.1% women and 69.8% men, with an average age of 63.9±9.6 years. In 98% of cases, squamous cell carcinoma was found. Of the palliative patients, three had SEMS placement, nine had chemotherapy, and twenty-two had radiotherapy. Following radiotherapy, dysphagia improved in 63.6% of palliative cases, or 68% of cases. Alcohol consumption and smoking were prevalent among men (76%).
Conclusions: The study highlights the burden of EC and the importance of tailored treatment strategies. While radical treatment remains the preferred approach, palliative care plays a crucial role in symptom management for advanced cases (alleviating dysphagia, improving QOL).
Metrics
References
Liu CQ, Ma YL, Qin Q, Wang PH, Luo Y, Xu PF, et al. Epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040. Thoracic Cancer. 2022;14(1):3. DOI: https://doi.org/10.1111/1759-7714.14745
Ranta RS, Sharma S, Chauhan M. Understanding Cancer Epidemiology in Himachal Pradesh, India. South Asian J Cancer. 2024;14(1):86-9. DOI: https://doi.org/10.1055/s-0044-1790222
Chen CC. Detecting Advanced Esophageal Cancer by Point of Care Ultrasonography. J Med Ultrasound. 2024;32(3):249. DOI: https://doi.org/10.4103/jmu.jmu_26_23
Uhlenhopp DJ, Then EO, Sunkara T, Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol. 2020;13(6):1010-21. DOI: https://doi.org/10.1007/s12328-020-01237-x
Vivaldi C, Catanese S, Massa V, Pecora I, Salani F, Santi S, et al. Immune Checkpoint Inhibitors in Esophageal Cancers: Are We Finally Finding the Right Path in the Mist? Int J Mol Sci. 2020;21(5):1658. DOI: https://doi.org/10.3390/ijms21051658
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2024;74(3):229-63.
Epidemiology of Esophageal Cancer. ClinicalKey. Available at: https://www.clinicalkey.com/#!/content/ playContent/1-s2.0-S0039610912001338?scrollTo= %23hl0000242. Accessed on 12 March 2025.
Sadaps M, Bhatt A, Chevalier C, Sohal D, Videtic G, McNamara MJ. A practical guide to the management of dysphagia in patients with metastatic esophageal cancer. Ann Esophagus. 2018;1(3). DOI: https://doi.org/10.21037/aoe.2018.03.01
Ang SY, Lim ML, Ng XP, Lam M, Chan MM, Lopez V, et al. Patients and home carers’ experience and perceptions of different modalities of enteral feeding. J Clin Nurs. 2019;28(17–18):3149-57. DOI: https://doi.org/10.1111/jocn.14863
Smith R, Bryant L, Reddacliff C, Hemsley B. A review of the impact of food design on the mealtimes of people with swallowing disability who require texture-modified food. Int J Food Design. 2022;7(1):7-28. DOI: https://doi.org/10.1386/ijfd_00034_1
Seshadri S, Sellers CR, Kearney MH. Balancing Eating With Breathing: Community-Dwelling Older Adults’ Experiences of Dysphagia and Texture-Modified Diets. Gerontologist. 2018;58(4):749-58. DOI: https://doi.org/10.1093/geront/gnw203
Halpern AL, McCarter MD. Palliative Management of Gastric and Esophageal Cancer. Surg Clin North Am. 2019;99(3):555-69. DOI: https://doi.org/10.1016/j.suc.2019.02.007
Touchefeu Y, Archambeaud I, Landi B, Lièvre A, Lepère C, Rougier P, et al. Chemotherapy versus self-expanding metal stent as primary treatment of severe dysphagia from unresectable oesophageal or gastro-oesophageal junction cancer. Digestive Liver Dis. 2014;46(3):283-6. DOI: https://doi.org/10.1016/j.dld.2013.10.012
Ross WA, Alkassab F, Lynch PM, Ayers GD, Ajani J, Lee JH, et al. Evolving role of self-expanding metal stents in the treatment of malignant dysphagia and fistulas. Gastroint Endosc. 2007;65(1):70-6. DOI: https://doi.org/10.1016/j.gie.2006.04.040
Homs MY, Steyerberg EW, Eijkenboom WM, Tilanus HW, Stalpers LJ, Bartelsman JF, et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. The Lancet. 2004;364(9444):1497-504. DOI: https://doi.org/10.1016/S0140-6736(04)17272-3
Welsch J, Kup PG, Nieder C, Khosrawipour V, Bühler H, Adamietz IA, et al. Survival and Symptom Relief after Palliative Radiotherapy for Esophageal Cancer. J Cancer. 2016;7(2):125. DOI: https://doi.org/10.7150/jca.13655
Rosenblatt E, Jones G, Sur RK, Donde B, Salvajoli JV, Ghosh-Laskar S, et al. Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: A prospective multi-centre randomized trial of the International Atomic Energy Agency. Radiother Oncol. 2010;97(3):488-94. DOI: https://doi.org/10.1016/j.radonc.2010.09.001
Dai Y, Li C, Xie Y, Liu X, Zhang J, Zhou J, et al. Interventions for dysphagia in oesophageal cancer. Cochrane Database Syst Rev. 2014;2014(10):CD005048.
Pichel RC, Araújo A, Domingues VDS, Santos JN, Freire E, Mendes AS, et al. Best Supportive Care of the Patient with Oesophageal Cancer. Cancers. 2022;14(24):6268. DOI: https://doi.org/10.3390/cancers14246268
Mellow MH, Pinkas H. Endoscopic Laser Therapy for Malignancies Affecting the Esophagus and Gastroesophageal Junction: Analysis of Technical and Functional Efficacy. Arch Int Med. 1985;145(8):1443-6. DOI: https://doi.org/10.1001/archinte.1985.00360080117017
Jain S, Dhingra S. Pathology of esophageal cancer and Barrett’s esophagus. Ann Cardiothorac Surg. 2017;6(2):99-109. DOI: https://doi.org/10.21037/acs.2017.03.06
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-63. DOI: https://doi.org/10.3322/caac.21834
Choksi D, Kolhe KM, Ingle M, Rathi C, Khairnar H, Chauhan SG, et al. Esophageal carcinoma: An epidemiological analysis and study of the time trends over the last 20 years from a single center in India. J Family Med Prim Care. 2020;9(3):1695-9. DOI: https://doi.org/10.4103/jfmpc.jfmpc_1111_19
Sjoquist KM, Burmeister BH, Smithers BM, Zalcberg JR, Simes RJ, Barbour A, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011;12(7):681-92. DOI: https://doi.org/10.1016/S1470-2045(11)70142-5
Kranzfelder M, Schuster T, Geinitz H, Friess H, Büchler P. Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer. Br J Surg. 2011;98(6):768-83. DOI: https://doi.org/10.1002/bjs.7455
van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, et al; CROSS Group. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074-84. DOI: https://doi.org/10.1056/NEJMoa1112088
Javed A, Pal S, Dash NR, Ahuja V, Mohanti BK, Vishnubhatla S, et al. Palliative Stenting With or Without Radiotherapy for Inoperable Esophageal Carcinoma: A Randomized Trial. J Gastrointest Canc. 2012;43(1):63-9. DOI: https://doi.org/10.1007/s12029-010-9206-4
Downloads
Published
How to Cite
Issue
Section
